ARTICLE | Financial News
Another C-suite departure at Immunocore
September 4, 2018 10:34 PM UTC
Chief Strategy and Business Officer Kevin Pojasek has left Immunocore Ltd. (Abingdon, U.K.) to join SV Health Investors as venture partner. Pojasek is the fifth C-level executive to leave the TCR company since former CEO Eliot Forster stepped down in February. Chief Commercial Officer Andrew Hotchkiss is interim CEO...
BCIQ Company Profiles